Bellevue Group AG bought a new stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor bought 174,152 shares of the company’s stock, valued at approximately $2,966,000.
Other hedge funds have also recently modified their holdings of the company. Rhumbline Advisers raised its stake in BrightSpring Health Services by 1.5% in the 4th quarter. Rhumbline Advisers now owns 73,583 shares of the company’s stock worth $1,253,000 after acquiring an additional 1,118 shares during the last quarter. MetLife Investment Management LLC lifted its holdings in BrightSpring Health Services by 4.9% in the fourth quarter. MetLife Investment Management LLC now owns 33,117 shares of the company’s stock valued at $564,000 after acquiring an additional 1,548 shares during the period. Quarry LP purchased a new stake in BrightSpring Health Services during the fourth quarter worth $29,000. Legal & General Group Plc boosted its stake in shares of BrightSpring Health Services by 4.8% during the 4th quarter. Legal & General Group Plc now owns 64,631 shares of the company’s stock worth $1,101,000 after acquiring an additional 2,945 shares in the last quarter. Finally, R Squared Ltd purchased a new position in BrightSpring Health Services during the fourth quarter worth approximately $74,000.
BrightSpring Health Services Price Performance
NASDAQ:BTSG opened at $20.87 on Friday. BrightSpring Health Services, Inc. has a one year low of $10.15 and a one year high of $24.82. The stock has a market cap of $3.65 billion, a PE ratio of -80.27 and a beta of 2.02. The stock has a 50 day moving average price of $17.62 and a 200 day moving average price of $18.50. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35.
Wall Street Analyst Weigh In
Separately, UBS Group lifted their target price on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $21.67.
View Our Latest Analysis on BTSG
BrightSpring Health Services Profile
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Featured Articles
- Five stocks we like better than BrightSpring Health Services
- 10 Best Airline Stocks to Buy
- Magnificent 7 Stocks Send a Dire Warning to Markets
- What is a Special Dividend?
- Why Spotify Stock Still Has Room to Run in 2025
- Insider Trades May Not Tell You What You Think
- Buy the Dip: Top Tech Stocks Analysts Say Are Undervalued
Want to see what other hedge funds are holding BTSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BrightSpring Health Services, Inc. (NASDAQ:BTSG – Free Report).
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.